Analyst firms · H.C. Wainwright · MIRM

H.C. Wainwright MIRM price target and rating history

Mirum Pharmaceuticals Inc. (MIRM) · Health Care

H.C. Wainwright rates Mirum Pharmaceuticals Inc. (MIRM) Buy with a $73 price target, as of its latest action on May 19, 2025. It has published 4 rating actions on MIRM since September 2021, including 0 upgrades and 0 downgrades. Across 3 firms with a MIRM price target in the last 12 months, the median target is $145.

Current rating
Buy
Price target
$73
Median target, all firms
$145
Actions on MIRM
4

H.C. Wainwright price target on MIRM

$73$62$5120222023202420252026
H.C. Wainwright price target on MIRM, each point a stated target, September 2021 to May 2025.

Every H.C. Wainwright rating on MIRM

How other firms rate MIRM

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
CitigroupBuy$145Jun 2, 2026
Wolfe ResearchOutperform$145May 19, 2026
RBC Capital MarketsOutperform$130Feb 18, 2026

Questions about H.C. Wainwright and MIRM

What is H.C. Wainwright's price target for MIRM?
H.C. Wainwright's latest stated price target for Mirum Pharmaceuticals Inc. (MIRM) is $73, from its action on May 19, 2025.
What is H.C. Wainwright's rating on MIRM?
H.C. Wainwright rates MIRM Buy, a bullish rating, as of May 19, 2025.
When did H.C. Wainwright last change its view on MIRM?
On May 19, 2025, H.C. Wainwright resumes coverage at Buy, price target $73.
How does H.C. Wainwright's MIRM target compare with other analysts?
Across 3 firms with a MIRM price target in the last 12 months, the median target is $145.

More MIRM rating histories

All H.C. Wainwright ratingsMIRM news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.